|
With an ever increasing population suffering from or at risk from Diabetes, the SMi Group’s 8th Annual Diabetes Conference comes at a crucially important time within the pharmaceutical industry. In the US Diabetes is the sixth biggest killer and on average the eighth in high-income countries, evidence enough that we are at a crossroads with this disease. In attending the SMi Group’s 8th Annual Diabetes Conference you will gain insights into which direction to now go. Industry leaders will gather for your benefit to discuss new targets, next generation drugs, gluckinase activators and expenditure genes. Mechanisms of insulin sensitization without causing weight gain will also be discussed as will novel kinetic assays for metabolic drug discovery making your attendance at this industry leading event essential if you wish to keep up to date with your peers
5 Key Benefits of Attending
1, HEAR KEY UPDATES on novel targets for drug discovery through RNAi 2, UNDERSTAND new mechanisms of insulin sensitization without causing weight gain 3, GAIN INSIGHTS INTO the Diabetes licensing landscape 4, DISCOVER NEW WAYS into treating visceral obesity and insulin resistance 5, INVESTIGATE beta cell regeneration- the ultimate cure for Diabetes?
CONFIRMED SPEAKERS INCLUDE - Rebecca Taub, Vice President, Research, Metabolic Diseases, Therapeutic Area Head, F. Hoffmann- La Roche
- Richard Carr, Senior Director, Merck
- Dr Simon Westbrook, Associate Research Fellow, Biomarkers and Translational Biology, Pfizer
- Dr Matthew Coghlan, Candidate Drug Delivery Team Leader, Diabetes and Drug Discovery, AstraZeneca
- Dr Timothy Herpin, Director, Metabolic Disease Licensing, Bristol-Myers Squibb
- Dr David Ferrick, Chief Scientific Officer and Vice President, Metabolic Research, Seahorse Bioscience
LAST YEAR’S DELEGATES INCLUDED REPRESENTATIVES FROM THE FOLLOWING ORGANISATIONS
Roche Diagnostics Eli Lilly Solvay Merck Sanofi-Aventis Bristol-Myers Squibb Laboratories Dr Esteve Kowa Research Limited Asterand
THIS EVENT IS AIMED AT THOSE WITH THE FOLLOWING JOB FUNCTIONS, INCLUDING;
Clinical Research Manager Principal Scientist Director, Metabolic Research Director, Metabolic Disease Licensing Director, Clinical Development Director, Drug Discovery
|
Events Home Page
